What's Inside
- About Us
- Research
- Clinical Trials
- Cancer Information
- News & Feature Stories
- Education & Events
- Make a Gift
Quick Links for:
Cancer Information Line
Ask about cancer, clinical trials, and how to make an appointment:
ccinfo@umn.edu
612-624-2620
Toll-free in IA, MN, ND, SD, WI: 1-888-CANCER MN
(1-888-226-2376)
John Kersey, M.D., led the study.
U of M researchers find leukemia's Achilles' heel
Researchers at the Masonic Cancer Center, University of Minnesota may have discovered the Achilles' heel of leukemia. Their finding is a major contribution toward resolving the long-standing medical controversy about which cells are the source of leukemias, cancer of the blood and bone marrow, and possibly other cancers. An article about the discovery is published in the May issue of the journal Cancer Cell.
News
Education & Events
Daniel Mulrooney, M.D., led the study.
U of M study: Children with leukemia living longer, productive lives
More than 90 percent of children and young adults who survive five years or longer after diagnosis and treatment for acute myeloid leukemia (AML) are alive 20 years later and leading productive lives, according to a U of M study published in the May 1 issue of the journal Cancer. However, the study's authors caution that these survivors need to be regularly evaluated and treated for health problems that may occur later in life as a result of their initial cancer and its treatment. Learn more.
Spring Poster Session and Symposium
The Ninth Annual Spring Poster Session and Symposium will be Thursday, May 15 from 11 a.m. to 1:30 p.m. in the Cancer Center Research Building. The event highlights research supported by the Masonic Cancer Center's scientific facilities and services. John Kersey, M.D., founding director emeritus, will be moderator for the oral presentations. Speakers include Eric Rahrmann, Amy Skubitz, Ph.D., and Ashish Kumar, M.D., Ph.D. Event details.